Rectal Adenocarcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2007-11-14
Clinical Trial Update: XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma [Phase 2]
This Phase 2 trial evaluates neoadjuvant therapy with XELOX plus bevacizumab followed by capecitabine plus bevacizumab with radiotherapy in …